Cargando…

The Inflammatory Profile of CTEPH-Derived Endothelial Cells Is a Possible Driver of Disease Progression

Chronic thromboembolic pulmonary hypertension (CTEPH) is a form of pulmonary hypertension characterized by the presence of fibrotic intraluminal thrombi and causing obliteration of the pulmonary arteries. Although both endothelial cell (EC) dysfunction and inflammation are linked to CTEPH pathogenes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Smolders, Valérie F. E. D., Lodder, Kirsten, Rodríguez, Cristina, Tura-Ceide, Olga, Barberà, Joan Albert, Jukema, J. Wouter, Quax, Paul H. A., Goumans, Marie José, Kurakula, Kondababu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067175/ https://www.ncbi.nlm.nih.gov/pubmed/33810533 http://dx.doi.org/10.3390/cells10040737

Ejemplares similares

Endothelial Dysfunction in Pulmonary Hypertension: Cause or Consequence?
por: Kurakula, Kondababu, et al.
Publicado: (2021)

Derivation and characterisation of endothelial cells from patients with chronic thromboembolic pulmonary hypertension
por: Tura-Ceide, Olga, et al.
Publicado: (2021)

Metabolic Alterations in Cardiopulmonary Vascular Dysfunction
por: Smolders, Valérie Françoise, et al.
Publicado: (2019)

Thoracic Aortic Aneurysm Development in Patients with Bicuspid Aortic Valve: What Is the Role of Endothelial Cells?
por: van de Pol, Vera, et al.
Publicado: (2017)

Regulatory RNAs controlling vascular (dys)function by affecting TGF-ß family signalling
por: Kurakula, Kondababu, et al.
Publicado: (2015)

Pulmonary Endothelial Dysfunction and Thrombotic Complications in Patients with COVID-19
por: Rodríguez, Cristina, et al.
Publicado: (2021)

Protein network analyses of pulmonary endothelial cells in chronic thromboembolic pulmonary hypertension
por: Nukala, Sarath Babu, et al.
Publicado: (2021)

Updated Perspectives on Pulmonary Hypertension in COPD
por: Blanco, Isabel, et al.
Publicado: (2020)

BMP Receptor Inhibition Enhances Tissue Repair in Endoglin Heterozygous Mice
por: Bakker, Wineke, et al.
Publicado: (2021)

The BMP Receptor 2 in Pulmonary Arterial Hypertension: When and Where the Animal Model Matches the Patient
por: Happé, Chris, et al.
Publicado: (2020)

Cigarette smoke challenges bone marrow mesenchymal stem cell capacities in guinea pig
por: Tura-Ceide, Olga, et al.
Publicado: (2017)

Endothelial Colony Forming Cells as an Autologous Model to Study Endothelial Dysfunction in Patients with a Bicuspid Aortic Valve
por: van de Pol, Vera, et al.
Publicado: (2019)

Imbalance between endothelial damage and repair capacity in chronic obstructive pulmonary disease
por: García-Lucio, Jéssica, et al.
Publicado: (2018)

Endothelial dysfunction in pulmonary arterial hypertension: loss of cilia length regulation upon cytokine stimulation
por: Dummer, Anneloes, et al.
Publicado: (2018)

Reply to: COVID-19 and Coagulopathy
por: Rodríguez, Cristina, et al.
Publicado: (2021)

Atrophy signaling pathways in respiratory and limb muscles of guinea pigs exposed to chronic cigarette smoke: role of soluble guanylate cyclase stimulation
por: Peinado, Víctor Ivo, et al.
Publicado: (2023)

Differences and Similarities between the Lung Transcriptomic Profiles of COVID-19, COPD, and IPF Patients: A Meta-Analysis Study of Pathophysiological Signaling Pathways
por: Aguilar, Daniel, et al.
Publicado: (2022)

Riociguat in Patients with CTEPH and Advanced Age and/or Comorbidities
por: Barnikel, Michaela, et al.
Publicado: (2022)

NOVEL CTEPH MIMICKERS IN THE COVID-19 ERA
por: Pietrowicz, Rylie, et al.
Publicado: (2022)

Blood Flow Disturbances in Congenital Heart Disease: Is Neuroblastoma Suppressor of Tumorigenicity 1 a Target for Preventing Pulmonary Vascular Remodeling?
por: Tura-Ceide, Olga
Publicado: (2022)

Metabolic profile in endothelial cells of chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension
por: Smolders, V. F. E. D., et al.
Publicado: (2022)

Exacerbated inflammatory signaling underlies aberrant response to BMP9 in pulmonary arterial hypertension lung endothelial cells
por: Szulcek, Robert, et al.
Publicado: (2020)

Central versus Peripheral CTEPH—Clinical and Hemodynamic Specifications
por: Kaldararova, Monika, et al.
Publicado: (2022)

Inhibition of the prolyl isomerase Pin1 improves endothelial function and attenuates vascular remodelling in pulmonary hypertension by inhibiting TGF-β signalling
por: Kurakula, Kondababu, et al.
Publicado: (2021)

Soluble guanylate cyclase stimulation reduces oxidative stress in experimental Chronic Obstructive Pulmonary Disease
por: Paul, Tanja, et al.
Publicado: (2018)

Altered TGFβ/SMAD Signaling in Human and Rat Models of Pulmonary Hypertension: An Old Target Needs Attention
por: Sanada, Takayuki Jujo, et al.
Publicado: (2021)

Ambrisentan for treatment of inoperable chronic thromboembolic pulmonary hypertension (CTEPH)
por: Escribano-Subias, Pilar, et al.
Publicado: (2019)

Epidemiology of chronic thromboembolic pulmonary hypertension (CTEPH) in the Czech Republic
por: Jansa, Pavel, et al.
Publicado: (2022)

Effects of Exercise Training on Circulating Biomarkers of Endothelial Function in Pulmonary Arterial Hypertension
por: Rodríguez-Chiaradía, Diego A., et al.
Publicado: (2023)

Real-World Switching to Riociguat: Management and Practicalities in Patients with PAH and CTEPH
por: Gall, Henning, et al.
Publicado: (2018)

Switching to riociguat: a potential treatment strategy for the management of CTEPH and PAH
por: Benza, Raymond L., et al.
Publicado: (2020)

Cardiopulmonary exercise testing and pulmonary function testing for predicting the severity of CTEPH
por: Zhu, Hanqing, et al.
Publicado: (2021)

Pulmonary artery sarcoma presenting as chronic thromboembolic pulmonary hypertension (CTEPH)
por: Ampatzidou, Fotini, et al.
Publicado: (2023)

Endothelial Dysfunction and Cardiovascular Risk in Obstructive Sleep Apnea: A Review Article
por: Peracaula, Miriam, et al.
Publicado: (2022)

Association Between Systemic and Pulmonary Vascular Dysfunction in COPD
por: Piccari, Lucilla, et al.
Publicado: (2020)

Progenitor cell mobilisation and recruitment in pulmonary arteries in chronic obstructive pulmonary disease
por: Tura-Ceide, Olga, et al.
Publicado: (2019)

Survivin inhibition with YM155 ameliorates experimental pulmonary arterial hypertension
por: Blanco, Isabel, et al.
Publicado: (2023)

Local and Systemic RAGE Axis Changes in Pulmonary Hypertension: CTEPH and iPAH
por: Moser, Bernhard, et al.
Publicado: (2014)

Quality of initial anticoagulant treatment and risk of CTEPH after acute pulmonary embolism
por: Boon, Gudula J. A. M., et al.
Publicado: (2020)

Haemodynamic effects of riociguat in CTEPH and PAH: a 10-year observational study
por: Yang, Suqiao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_j66nkkfvci3s9lo0o0tq2ol6ku